T Shirahama

4.5k citations

77 papers · 3.7k indexed · 1 hit paper · h-index 34

Molecular Biology top 5%
Physiology top 2%
Oncology top 5%
Surgery top 10%
Genetics top 5%

Co-authors: Alan S. Cohen M Skinner F Gejyo Masaaki Arakawa Yoshihei Hirasawa Chohei Sakakura Elizabeth Sweeney Tadayoshi Kunitomo
Topics: Amyloidosis: Diagnosis, Treatment, Outcomes (22 papers)Alzheimer's disease research and treatments (17 papers)Drug Transport and Resistance Mechanisms (10 papers)
Cited by: Nephrology Physiology Molecular Biology
Journals: Journal of Biological Chemistry Journal of Clinical Investigation The Journal of Experimental Medicine
Partner nations: Japan United States Netherlands

In The Last Decade

T Shirahama

77 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A new form of amyloid protein associated with chronic hemodialysis was identified as β2-microglobulin

1985 726 citations F Gejyo, Masaaki Arakawa et al. Biochemical and Biophysical Research Communications profile →

Peers

Countries citing papers authored by T Shirahama

Since Specialization

Citations

This map shows the geographic impact of T Shirahama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T Shirahama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T Shirahama more than expected).

Fields of papers citing papers by T Shirahama

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T Shirahama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T Shirahama. The network helps show where T Shirahama may publish in the future.

Co-authorship network of co-authors of T Shirahama

This figure shows the co-authorship network connecting the top 25 collaborators of T Shirahama. A scholar is included among the top collaborators of T Shirahama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T Shirahama. T Shirahama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Inhibition of 5‐lipoxygenase pathway suppresses the growth of bladder cancer cells 2006 ·International Journal of Urology ·(unknown),Kenryu Nishiyama,T Shirahama	38
2	Overexpression of cyclooxygenase‐2 in high‐grade human transitional cell carcinoma of the upper urinary tract 2003 ·British Journal of Urology ·S. Oku,Midoriko Higashi,(unknown),Kazunobu Sueyoshi,Hideki Enokida,(unknown),Shingo Yonezawa,T Shirahama	11
3	Relation between cyclooxygenase-2 expression and tumor invasiveness and patient survival in transitional cell carcinoma of the urinary bladder 2001 ·Cancer ·T Shirahama,(unknown),Suminori Akiba,Chohei Sakakura	103
4	Multidisciplinary treatment, including laser hyperthermia, for extensive regional metastasis of a penile tumor 1999 ·International Journal of Urology ·T Shirahama,Hideki Enokida,(unknown),(unknown),Masaru Ohyama,Yoshitada Ohi	1
5	Selectivity of Sphingosine-Induced Apoptosis 1998 ·Biochemical and Biophysical Research Communications ·Chouhei Sakakura,Elizabeth Sweeney,T Shirahama,Akeo Hagiwara,Toshiharu Yamaguchi,Toshio Takahashi,Sen‐itiroh Hakomori,Yasuyuki Igarashi	36
6	Sphingosine induces apoptosis in androgen‐independent human prostatic carcinoma DU‐145 cells by suppression of bcl‐X_L gene expression 1997 ·FEBS Letters ·T Shirahama,Chohei Sakakura,Elizabeth Sweeney,Masayuki Ozawa,(unknown),Kenryu Nishiyama,Yoshitada Ohi,Yasuyuki Igarashi	50
7	Overexpression ofBax sensitizes breast cancer MCF-7 cells to cisplatin and etoposide 1997 ·Surgery Today ·Chouhei Sakakura,Elizabeth Sweeney,T Shirahama,Yasuyuki Igarashi,(unknown),Hiroyuki Tsujimoto,Tsutomu Imanishi,(unknown),(unknown),Junya Yamazaki,Akeo Hagiwara,Toshiharu Yamaguchi,Kiyoshi Sawai,Toshio Takahashi	33
8	Metanestin, a glycoprotein with metastasis-associated expression in transitional cell carcinoma of the urinary bladder 1997 ·International Journal of Cancer ·(unknown),T Shirahama,Teruo Miyauchi,(unknown),(unknown),Hisako Muramatsu,Masayuki Ozawa,(unknown),T. Muramatsu	11
9	Sphingosine and its methylated derivative N,N-dimethylsphingosine (DMS) induce apoptosis in a variety of human cancer cell lines 1996 ·International Journal of Cancer ·Elizabeth Sweeney,Chouhei Sakakura,T Shirahama,Atsushi Masamune,(unknown),Sen‐itiroh Hakomori,Yasuyuki Igarashi	157
10	Overexpression of bax sensitizes human breast cancer MCF-7 cells to radiation-induced apoptosis 1996 ·International Journal of Cancer ·Chouhei Sakakura,Elizabeth Sweeney,T Shirahama,Yasuyuki Igarashi,Sen‐itiroh Hakomori,(unknown),Hiroyuki Tsujimoto,Tsutomu Imanishi,Masaharu Ohgaki,(unknown),Junya Yamazaki,Akeo Hagiwara,Toshiharu Yamaguchi,Kiyoshi Sawai,Toshio Takahashi	149
11	Intravesical instillation chemotherapy of adriamycin with or without verapamil for the treatment of superficial bladder cancer: the final results of a collaborative randomized trial 1994 ·Cancer Chemotherapy and Pharmacology ·Tomoyasu Tsushima,Hiroyuki Ohmori,Yoshitada Ohi,T Shirahama,Motoshi Kawahara,Yosuke Matsumura,Yasuo Ohashi	6
12	The binding site for fucose-binding proteins ofLotus tetragonolobus is a prognostic marker for transitional cell carcinoma of the human urinary bladder 1993 ·Cancer ·T Shirahama,(unknown),Takashi Muramatsu,(unknown),Yoshitada Ohi,Tomoyasu Tsushima,(unknown),Hiroyuki Ohmori,Yoshihiko Hirao,(unknown)	25
13	Recombinant Human Tumour Necrosis Factor‐α (rhTNF‐α) and rhTNF‐α Analogue Enhance Amyloid Deposition in the Syrian Hamster 1993 ·Scandinavian Journal of Immunology ·Théo Niewold,E. Gruys,Tsutomu Arakawa,T Shirahama,Robert Kisilevsky	19
14	Intravesical instillation of Adriamycin in the presence or absence of verapamil for the treatment of superficial bladder cancer: preliminary report of a collaborative study 1992 ·Cancer Chemotherapy and Pharmacology ·Yoshitada Ohi,Hiroyuki Ohmori,T Shirahama,Motoshi Kawahara,Yosuke Matsumura,Tomoyasu Tsushima,Yasuo Ohashi	13
15	Expression of a carbohydrate signal, sialyl dimeric Lex antigen, is associated with metastatic potential of transitional cell carcinoma of the human urinary bladder 1991 ·Biochemical and Biophysical Research Communications ·(unknown),Hisako Muramatsu,T Shirahama,Takashi Muramatsu,Yoshitada Ohi	55
16	Generation and use of site-specific antibodies to serum amyloid A for probing amyloid A development. 1990 ·The Journal of Immunology ·Katsutoshi Miura,S T Ju,Alan S. Cohen,T Shirahama	18
17	Murine tissue macrophages synthesize and secrete amyloid proteins different to amyloid A (AA) 1989 ·European Journal of Clinical Investigation ·Giuliano Ramadori,H. Rieder,Jean D. Sipe,T Shirahama,K. H. Meyer zum Büschenfelde	12
18	Histochemical and immunohistochemical characterization of amyloid associated with chronic hemodialysis as beta 2-microglobulin. 1985 ·PubMed ·T Shirahama,(unknown),Alan S. Cohen,F Gejyo,Masaaki Arakawa,Masashi Suzuki,Yoshihei Hirasawa	76
19	The SJL/J mouse: a new model for spontaneous age-associated amyloidosis. I. Morphologic and immunochemical aspects. 1976 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·(unknown),(unknown),(unknown),(unknown),M D Benson,T Shirahama	38
20	Intralysosomal formation of amyloid fibrils. 1975 ·PubMed Central ·T Shirahama,Alan S. Cohen	140

About T Shirahama

T Shirahama is a scholar working on Oncology, Physiology and Molecular Biology, having authored 77 papers that have together received 3.7k indexed citations. Recurring topics across this work include Amyloidosis: Diagnosis, Treatment, Outcomes (22 papers), Alzheimer's disease research and treatments (17 papers) and Drug Transport and Resistance Mechanisms (10 papers). The work is most often cited by research in Nephrology (358 citations), Physiology (1.1k citations) and Molecular Biology (2.5k citations). T Shirahama has collaborated with scholars based in Japan, United States and Netherlands. Frequent co-authors include Alan S. Cohen, M Skinner, F Gejyo, Masaaki Arakawa, Yoshihei Hirasawa, Chohei Sakakura, Elizabeth Sweeney, Tadayoshi Kunitomo, Makiko Suzuki and Takao Yamada. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and The Journal of Experimental Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact